When was Enzymatics founded?

Enzymatics was founded in 2006 and raised its 1st funding round within a year of its incorporation.

Where is Enzymatics located?

Enzymatics is headquartered in Beverly, United States.

How many employees does Enzymatics have?

As of May 31, 2026, the latest employee count at Enzymatics is 72.

Is Enzymatics a funded company?

Enzymatics is a funded company, having raised a total of $5.39M across 2 funding rounds to date. The company's 1st funding round was a $***** Convertible Debt round, raised on Sep 2006.

When was the latest funding round of Enzymatics?

Enzymatics' latest funding was a $***** Series A round on Aug 01, 2013, with participation from 0 investor.

Where does Enzymatics rank among its competitors?

Enzymatics ranks 99th amongst 985 active competitors, of which 86 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was RareCyte, which secured $658K in May, 2025.

Who are the top competitors of Enzymatics?

Enzymatics' top competitors include Abcam, Enzo and Sino Biological. Among them, RareCyte secured the most recent funding round in May, 2025.

Enzymatics - 2026 Company Profile, Team, Funding & Competitors

Enzymatics is an acquired company based in Beverly (United States), founded in 2006 by Stephen Picone and Christopher Benoit. It operates as a Manufacturer of enzymes and DNA sample preparation kits for next-generation sequencing. Enzymatics has raised $5.39M in funding. The company has 985 active competitors, including 86 funded and 138 that have exited. Its top competitors include companies like Abcam, Enzo and Sino Biological.

Company Details

Manufacturer of enzymes and DNA sample preparation kits for next-generation sequencing. The company also has the ability to develop a custom reagent or formulation to meet a specific set of customer requirements. The company also provides DNA sample preparation kits for NGS sequencing (Illumina, Ion Torrent).

Website: enzymatics.com
Social

Key Metrics

Founded Year

2006

Location

Beverly, United States

Stage

Acquired

Total Funding

$5.39M in 2 rounds

Latest Funding Round

Series A, Aug 01, 2013, $*****

Investors

PBM Capital & 1 more

Ranked

99^th among 985 active competitors

Employee Count

72 as on May 31, 2026

Similar Companies

Enzo & 409 more

Exit Details

Acquired by Qiagen (Jan 11, 2015)

View Enzymatics' full profile

Enzymatics got acquired by Qiagen on Jan 11, 2015.

Click here to take a look at Enzymatics's acquisition in detail

Enzymatics has raised a total funding of $5.39M over 2 rounds. Its first funding round was on Sep 2006. Enzymatics has 2 institutional investors.

Here is the list of recent funding rounds of Enzymatics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 01, 2013	1265787	Series A	9893842	7005453	3676348	8943287
Sep 2006	1365392	Convertible Debt	9653039	9019652	5704502	5099267

Access funding benchmarks and valuations. Sign up today!

View details of Enzymatics's funding rounds and investors

The founders of Enzymatics are Stephen Picone and Christopher Benoit.

Here are the details of Enzymatics' key team members:

Stephen Picone: Co-Founder & CSO of Enzymatics.
Christopher Benoit: Co-Founder & COO of Enzymatics.
Contact Info: 1 email address

View details of Enzymatics's Founder profiles and Board Members

Enzymatics' employee count trend

Enzymatics has 72 employees as of May 26. Here is Enzymatics's employee count trend over the years:

Uncover Enzymatics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Enzymatics include Abcam, Enzo and Sino Biological. Here is the list of Top 10 competitors of Enzymatics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	75/100
2nd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	67/100
3rd	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	67/100
4th	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
5th	LGC 1842, Teddington (United Kingdom), Acquired	Provider of analytical testing, reference materials, and diagnostic and therapeutic products	-	Omnes Capital, Broad Vision Funds & 3 others	64/100
6th	Paragon Genomics 2015, San Francisco (United States), Series A	Provider of technologies and solutions genomic research and precision medicine	$8M	Fosun·Star Future Capital, Co-win Ventures ... & 3 others	62/100
7th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
8th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	59/100
9th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
10th	RareCyte 2009, Seattle (United States), Series C	Developer of technologies for the analysis of rare and single cells in the blood	$114M	Arboretum Ventures, Health Quest Capital ... & 11 others	57/100
99th	Enzymatics 2006, Beverly (United States), Acquired	Manufacturer of enzymes and DNA sample preparation kits for next-generation sequencing	$5.39M	PBM Capital, TL Ventures	38/100